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Abstract 
Problem/Condition: Epilepsy is a brain disorder characterized by brief, recurrent disturbances in the normal electri­
cal functions of the brain that result in seizures. Few population-based studies of epilepsy have been published for the 
United States, and the prevalence is expected to increase with the aging of the population. This is the first multistate 
study examining the prevalence of self-reported epilepsy and active epilepsy and includes an examination of 
socioedemographic and behavioral characteristics and of health-related quality of life among adults with epilepsy. 
Reporting Period Covered: Data from the 2005 Behavioral Risk Factor Surveillance System (BRFSS) are presented 
for 19 states. 
Description of System: BRFSS is an ongoing, state-based, random-digit–dialed telephone survey of the 
noninstitutionalized U.S. population aged >18 years. BRFSS collects information on health risk behaviors and pre­
ventive health services related to leading causes of death and morbidity. In 2005, 19 states included questions on 
epilepsy or seizure disorder. 
Results/Interpretation: During 2005, 1.65% of noninstitutionalized adults from 19 states reported that they had 
ever been told by a doctor that they had epilepsy or seizure disorder (i.e., a history of epilepsy); 0.84% reported having 
active epilepsy (i.e., a history of epilepsy and currently taking medication or reporting one or more seizures during the 
past 3 months), and 0.75% were classified as having inactive epilepsy (i.e., a history of epilepsy or seizure disorder but 
currently not taking medicine to control epilepsy and no seizures in the 3 months preceding the survey). No substan­
tial differences among states in the prevalence of lifetime epilepsy, active epilepsy, or inactive epilepsy were detected. 
Prevalence estimates for active and inactive epilepsy revealed no significant differences by sex or race/ethnicity. 
Adults with a history of epilepsy and with active epilepsy were more likely to report fair or poor health, be unem­
ployed or unable to work, live in households with the lowest annual incomes, and have a history of co-occurring 
disorders (e.g., stroke or arthritis). Adults with a history of epilepsy and with active epilepsy also reported significantly 
worse health-related quality of life. Adults with a history of epilepsy were more likely to be obese, physically inactive, 
and current smokers. Among adults with active epilepsy with recent seizures, 16.1% reported not currently taking 
their epilepsy medication, and 65.1% reported having had more than one seizure in the past month. Among adults 
with a history of epilepsy, 23.7% reported cost as a barrier to seeking care from a doctor within the past year. A total 
of 34.9% of adults with active epilepsy with seizures reported not having seen a neurologist or an epilepsy specialist 
(i.e., a neurologist who specializes in treating epilepsy) in the previous year. 
Public Health Action: Additional descriptive and ana­
lytic studies of epilepsy occurrence in diverse U.S. com­
munities and populations are needed to better Corresponding author: Rosemarie Kobau, MPH, Division of Adult and 
Community Health, National Center for Chronic Disease Prevention and characterize epilepsy incidence rates, risk factors and
Health Promotion, CDC, 4770 Buford Hwy, N.E., MS K-51, Atlanta, etiologies, and types and severity, as well as epilepsy-GA 30347. Telephone: 770-488-6087; Fax: 770-488-5486; E-mail:
 
rkobau@cdc.gov. associated conditions and disabilities. Community-

based strategies that link health-care providers with 
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social services such as public transportation, mental health services, and employment services might improve quality of 
life in persons with epilepsy. Implementing educational programs developed by CDC and the Epilepsy Foundation for 
schools, emergency responders, employers, providers, and the general public can increase awareness about epilepsy and 
reduce stigma associated with this disorder. 
Introduction 
Epilepsy is one of the most common neurological disorders 
worldwide, affecting 50 million persons (1), including an 
estimated 2.1 to 2.7 million persons in the United States (2,3). 
The condition is a brain disorder characterized by recurrent, 
transient disturbances in the electrical functions of the brain 
that result in seizures. Signs and symptoms of seizures include 
sudden and transitory phenomena such as alterations of con­
sciousness, or involuntary motor, sensory, autonomic, or psy­
chic effects (3–5). Many persons with epilepsy also experience 
certain signs and symptoms immediately after seizures, such 
as memory impairment, fatigue, depressive symptoms, or anxi­
ety (i.e., the postictal state) (6). Seizures are broadly classified 
into generalized, partial, and unclassifiable types, with addi­
tional subcategories; persons can experience more than one 
seizure type (4,5). 
Seizures and epilepsy result from many causes, including those 
that are preventable. Causes include traumatic brain injury, stroke, 
central nervous system (CNS) infections (e.g., meningitis and 
encephalitis), brain tumor, idiopathic causes presumed to be 
genetic, and others (5). Not all persons with seizures have epi­
lepsy. Epilepsy is not diagnosed when seizures are provoked by 
acute and temporary conditions that affect brain function (e.g., 
fever, acute systemic metabolic disturbance, or alcohol with­
drawal). Rather, a person receives a diagnosis of epilepsy only 
when seizures recur in the absence of such acute conditions and 
when any underlying pathological conditions, if identifiable, are 
chronic (4,5). Although persons of all ages can develop epilepsy, 
incidence rates are higher among young children and older adults 
because risk factors for epilepsy are more common in these age 
groups (2,3). Recurrent seizures often result in limitations in 
activities, depression, anxiety, and impaired quality of life and 
can increase risk for death (7–9). Misconceptions about epilepsy 
and its causes and consequences are prevalent, contributing to 
stigma associated with the condition and increasing challenges 
for persons living with this disorder (1,8–12). 
Texas, Georgia, Tennessee, and South Carolina were among 
the first states to use the state-based BRFSS to assess state-
level epilepsy prevalence using five standardized questions 
developed by the CDC Epilepsy Program (13–17). In 2003 
and 2005, CDC, in partnership with the University of Cali­
fornia, Los Angeles, used the California Health Interview Sur­
vey (CHIS) to assess epilepsy prevalence in California (16). 
Although case definitions differed among these state studies 
depending on the questions used, lifetime prevalence estimates 
ranged from 1.2% to 2.6%, and prevalence estimates for 
active epilepsy ranged from 0.7% to 1.6% (13–16). 
With CDC financial and technical support, local founda­
tion affiliates of the national Epilepsy Foundation worked with 
state departments of public health to incorporate at least one 
of five standardized epilepsy questions into the 2005 Behav­
ioral Risk Factor Surveillance System (BRFSS). Nineteen states 
accepted one or more questions. This study is the first to 
examine the prevalence of self-reported epilepsy in these states 
and the prevalence of active epilepsy in some states. 
Sociodemographic and behavioral characteristics, health-
related quality of life (HRQOL), and life satisfaction of 
persons by epilepsy status also were examined. 
Methods 
BRFSS is an ongoing, state-based, random-digit–dialed tele­
phone survey of the civilian, noninstitutionalized population 
aged >18 years that tracks the prevalence of key health and 
safety-related behaviors and characteristics (18). The question­
naire consists of three parts: 1) core questions asked in all 50 
states, the District of Columbia, and three territories; 2) supple­
mental modules (i.e., a series of questions on a specific topic 
such as arthritis, diabetes, or depression); and 3) state-added 
questions. Each state decides which supplemental modules 
and state-added questions to include in its BRFSS survey. 
BRFSS also includes standardized questions on socio­
demographic and behavioral characteristics and self-reported 
chronic diseases. The complete BRFSS survey is available at 
http://www.cdc.gov/brfss (18). BRFSS data are weighted to 
reflect the age, sex, and racial/ethnic distribution of the state’s 
estimated population during the survey year. 
Twelve states included all five epilepsy questions as state-
added questions in their 2005 BRFSS questionnaire; one state 
included three questions; four states included two questions; 
and two states included one question.* The first question was, 
“Have you ever been told by a doctor that you have a seizure 
disorder or epilepsy?” (response options: “yes,” “no,” “don’t 
know,” and “refused”). Participants who answered “yes” to this 
question were asked some or all of the remaining questions: 
* All five questions: Arizona, Delaware, Georgia, Michigan, Missouri, New 
York, Oregon, Pennsylvania, South Carolina, Tennessee, Washington, 
and Wyoming; three questions: Kentucky; two questions: Florida, Texas, 
Virginia, and Wisconsin; one question: Kansas and New Hampshire. 
 
 
3 Vol. 57 / SS-6 Surveillance Summaries 
2) “Are you currently taking any medicine to control your 
seizure disorder or epilepsy?” (response options: “yes,” “no,” 
“don’t know,” and “refused”); 3) “How many seizures have 
you had in the last 3 months?” (response options: “none,” 
“one,” “more than one,” “no longer have epilepsy or seizure 
disorder,” “don’t know,” and “refused”); 4) “In the past year, 
have you seen a neurologist or epilepsy specialist for your epi­
lepsy or seizure disorder?” (response options: “yes,” “no,” “don’t 
know,” and “refused”); and 5) “During the past 30 days, to 
what extent has epilepsy or its treatment interfered with your 
normal activities like working, school, or socializing with family 
or friends?” (response options: “not at all,” “slightly,” “moder­
ately,” “quite a bit,” “extremely,” “don’t know,” and “refused”). 
The lifetime prevalence (i.e., cumulative incidence) of self-
reported epilepsy was determined by affirmative responses to 
the first question. Respondents were classified as having 
active epilepsy if they responded “yes” to ever having been 
told by a doctor that they had a seizure disorder or epilepsy 
and also responded that they either were currently taking medi­
cation to control it, had one or more seizures in the past 
3 months, or both (Figure). Active epilepsy was further cat­
egorized by whether the respondent had experienced a seizure 
in the past 3 months (i.e., active epilepsy with or without 
recent seizures). Respondents who responded that they had 
ever been told by a doctor that they had a seizure disorder or 
epilepsy (i.e., had a history of epilepsy) but were not taking 
medication for epilepsy and had not had a seizure in the past 
3 months† were classified as those with inactive epilepsy 
(Figure). 
HRQOL was measured for all respondents, with and with­
out a history of epilepsy, with the following validated CDC 
Healthy Days questions (19): 1) “Now thinking about your 
physical health, which includes physical illness and injury, for 
how many days during the past 30 days was your physical 
health not good?” 2) “Now thinking about your mental health, 
which includes stress, depression, and problems with emo­
tions, for how many days during the past 30 days was your 
mental health not good?” and 3) “During the past 30 days, 
for about how many days did poor physical or mental health 
keep you from doing your usual activities, such as self-care, 
work, or recreation?” CDC methods for calculating HRQOL 
were used (19). In addition, all respondents were asked to 
respond to a question on self-rated health: “Would you say 
that in general your health is excellent, very good, good, fair, 
or poor?” Responses for self-rated health were classified into 
two groups for analysis: 1) excellent, very good, or good and 
2) fair or poor. 
Statistical software was used to account for the complex 
survey design. Data were weighted to obtain appropriate popu­
lation estimates, standard errors, and 95% confidence inter­
vals (CIs). Estimates were considered significantly different if 
CIs did not overlap. The total eligible number of BRFSS 
respondents among all 50 states was 556,117 adults; the 
median refusal rate was 14.4% (20). The Council of Ameri­
can Survey Organizations (CASRO) response rates among the 
19 states for the 2005 BRFSS survey ranged from 40.0% (New 
York) to 63.1% (Kansas) (median among 19 states: 51.1%); 
cooperation rates§ among respondents ranged from 67.6% 




A total of 2,207 adults from 19 states (1.65%, CI = 1.52– 
1.80) reported ever being told they had epilepsy (i.e., a his­
tory of epilepsy) (Table 1). Among 13 states that included 
three questions sufficient to classify epilepsy status, 919 
(0.84%; CI = 0.74–0.96) were classified as having active epi­
lepsy, and 693 (0.75%; CI = 0.65–0.86) were classified as 
having inactive epilepsy (Table 1). Some significant differ­
ences in prevalence were detected between states (e.g., Dela­
ware and Wyoming, New York and Washington). 
Characteristics of Adults with a History 
of Epilepsy 
Of persons ever told they had epilepsy (i.e., persons with a 
history of epilepsy), 55.9% were women, and half were aged 
35–44 (22.0%) to 45–54 years (22.7%); in addition, 74.1% 
were white, 8.8% were black, 11.2% were Hispanic, and 6.0% 
were of another race/ethnicity (Table 2). Compared with those 
without the disorder, a greater percentage of adults with a 
history of epilepsy had lower levels of education and income. 
A smaller percentage of persons with a history of epilepsy were 
married or part of an unmarried couple and a greater percent­
age were formerly married compared with those without the 
disorder. 
A smaller percentage of persons with a history of epilepsy 
were employed (45.8%) and a greater percentage (23.7%) were 
unable to work than those without epilepsy (61.6% and 4.8%, 
respectively) (Table 2). Nearly the same percentages of those 
with (17.0%) and without (16.3%) a history of epilepsy did 
† Including those who responded “no longer have epilepsy” to the seizure § The percentage of persons who completed interviews among all eligible 
frequency question. persons contacted. 
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FIGURE. Definitions of active and inactive epilepsy — Behavioral Risk Factor Surveillance System, 2005 
Ever been told by a doctor that you have 
a seizure disorder or epilepsy? 
Yes No 
No history of epilepsy Currently taking medication for 
epilepsy or seizure disorder? 
Yes No 






No longer have† 
Active 
epilepsy 






No longer have† 
Inactive 
epilepsy 
* Respondents were asked "How many seizures have you had in the last 3 months?” with response options of “none,” “one,” “more than one,” “no longer 
have epilepsy or seizure disorder,” “don’t know,” and "refused.”
†Approximately 1% of respondents reported no longer having epilepsy but also reported taking medication, thus remained classified as having active 
epilepsy cases. Approximately 11% of respondents reported no longer having epilepsy and reported not taking medication and were classified as 
having inactive epilepsy. 
not have health-care insurance. However, 23.7% of those with 
a history of epilepsy reported not being able to see a doctor in 
the past year because of the cost, compared with 13.4% of 
those without the disorder. A total of 69.0% of persons with a 
history of epilepsy reported having a checkup within the past 
year, a proportion similar to that in the general population. 
A significantly greater percentage of persons with a history 
of epilepsy were classified as obese compared with those with 
no history of epilepsy (30.1% versus 24.0%, respectively). A 
greater percentage of persons with a history of epilepsy were 
current smokers compared with those without the disorder 
(30.1% versus 20.9%, respectively) (Table 2). A total of 33.5% 
of persons with a history of epilepsy reported no exercise in 
the past 30 days compared with 24.5% of those without the 
disorder, and 37.0% of persons with a history of epilepsy 
reported fair or poor health, compared with 15.8% of those 
without the disorder (Table 2). In addition, 13.6% of those 
with a history the disorder reported rarely or never receiving 
the emotional support they needed, compared with 8.0% of 
those without the disorder (Table 2). A total of 16.6% of those 
with a history of epilepsy reported being dissatisfied or very 
dissatisfied with their life, compared with 5.4% of those with­
out the disorder (Table 2). 
Classification of Active and Inactive 
Epilepsy 
Among adults with a history of epilepsy, 48.8% reported cur­
rently taking medication to control their disorder (Table 3). Of 
those with a history of epilepsy, 15.0% reported having more 
than one seizure in the past 3 months; 8.1% had one seizure, 
and 71.0% had no seizures in the past 3 months (Table 3). A 
total of 5.9% of those with a history of epilepsy reported no 
longer having the disorder (self-determined) in response to the 
question on seizure frequency (Figure, Table 3). 
Of those classified with active epilepsy, 55.1% reported hav­
ing had no seizures in the past 3 months, 15.3% reported one 
seizure, and 28.6% reported more than one seizure; in addi­
tion, 6.9% of those classified with active epilepsy reported 
not taking medication for their seizure disorder but having 
had recent seizures. Although 1.0% of adults with active epi­
lepsy reported no longer having the disorder, they were classi­
fied as having active epilepsy because they also reported 
currently taking medication (Figure, Table 3). Among adults 
with active epilepsy and recent seizures, 16.1% reported not 
taking medication for their disorder, and 34.9% reported hav­
ing had one seizure in the past 3 months, with 65.1% having 
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had more than one seizure (Table 3). A total of 34.9% of 
adults with active epilepsy with recent seizures reported not 
seeing a neurologist or epilepsy specialist in the past year (Table 
3). Among adults with active epilepsy and no recent seizures, 
40.6% reported not having seen a neurologist or epilepsy spe­
cialist in the past year. 
Among persons with active epilepsy with recent seizures, 
32.9% reported that epilepsy or its treatment limited their 
abilities in the past month “quite a bit or extremely” com­
pared with 7.6% among those with no recent seizures. 
Characteristics of Adults Classified with 
Active Epilepsy 
Prevalence estimates for active and inactive epilepsy reveal 
no differences by sex or race/ethnicity (Table 4). Differences 
in prevalence occurred by age (e.g., 35–54 years versus 18–24 
years); however, these differences should be interpreted with 
caution because of the small sample sizes in certain age groups. 
Among persons with active epilepsy, 56.4% were women, 
and half were aged 35–54 years (22.1% aged 35–44 years, 
26.1% aged 45–54 years) (Table 5). A total of 80.4% of adults 
with active epilepsy were white, 11.0% were black, and 5.5% 
were Hispanic. A significantly greater percentage of those with 
active epilepsy reported not completing high school, compared 
with adults without the disorder, and a smaller percentage of 
adults with active epilepsy reported having some college edu­
cation (Table 5). Similar percentages with respect to educa­
tional attainment occurred among those with inactive epilepsy. 
A total of 47.7% of adults with active epilepsy and 40.7% 
of those with inactive epilepsy reported an annual household 
income of <$25,000, compared with 26.5% of adults with­
out the disorder. A significantly smaller percentage of persons 
with active epilepsy were married or part of an unmarried 
couple than those without the disorder, and a greater percent­
age of those with active epilepsy were formerly married com­
pared with those without the disorder (Table 5). 
Among adults with active epilepsy, 9.8% were unemployed, 
compared with 5.4% in those without a history of epilepsy. A 
total of 31.3% of those with active epilepsy and 15.4% of 
those with inactive epilepsy reported being unable to work, 
compared with 4.9% of those without the disorder (Table 5). 
Fair or poor health was reported by 48.5% of adults with 
active epilepsy and 28.5% of those with inactive epilepsy, both 
significantly more than the 15.8% of adults without the dis­
order (Table 6). A significantly greater percentage of adults 
with inactive epilepsy reported not having health-care insur­
ance (23.9%) compared with those with active epilepsy 
(10.9%) or those without the disorder (14.1%). From 63.1% 
to 71.5% of adults in these three groups reported having had 
a checkup within the past 2 years. However, a significantly 
greater percentage of adults with active epilepsy reported not 
being able to see a doctor in the past 12 months because of 
the cost. 
A total of 32.2% of adults with active epilepsy and 31.9% 
of those inactive epilepsy were classified as obese, compared 
with 23.3% of adults without the disorder (Table 6). A sig­
nificantly smaller percentage of adults with active epilepsy 
(60.7%) reported any exercise in the past 30 days compared 
with adults without the disorder (75.4%). Among those with 
active epilepsy or inactive epilepsy, 32.4% and 32.0% were 
current smokers, respectively, compared with 21.6% of those 
without the disorder. A smaller percentage of adults with 
active epilepsy (30.4%) reported drinking any alcohol in the 
past month than those without the disorder (53.4%). 
A greater percentage of adults with active epilepsy (15.7%) 
and inactive epilepsy (7.3%) reported having had a stroke than 
those with no history of the disorder (2.4%). Eight percent of 
adults with active epilepsy reported having heart disease, com­
pared with 4.8% of those with inactive epilepsy. Twenty per­
cent of adults with active epilepsy reported having asthma, 
approximately twice the proportion among those with inac­
tive epilepsy or without the disorder. A greater percentage of 
adults with active epilepsy (13.0%) and inactive epilepsy 
(14.9%) reported being told they had diabetes compared with 
those with no history of the disorder (7.7%). A significantly 
greater percentage of adults with active epilepsy or inactive 
epilepsy reported being told they had arthritis and reported 
current joint pain than those without the disorder (Table 6). 
A total of 21.6% of adults with active epilepsy reported 
getting the recommended 5 servings of fruits and vegetables a 
day, similar to those with inactive epilepsy (27.4%) and those 
without the disorder (26.4%). Approximately the same per­
centages of adults with and without the disorder reported 
receiving a flu shot in the past year. 
A significantly greater percentage of adults with active epi­
lepsy reported rarely or never getting the emotional support 
they needed (19.1%) than those without the disorder (7.6%). 
In addition, a greater percentage of those with active epilepsy 
were dissatisfied or very dissatisfied with their life (18.8%) 
than those without the disorder (5.7%) (Table 6). 
Sex and age were not associated with increased or decreased 
risk for active epilepsy with recent seizures (Table 7). How­
ever, a significantly greater percentage of Hispanics (79.2%) 
reported recent seizures than did whites (40.0%), and a greater 
percentage of persons with active epilepsy at the lowest 
annual household income level (57.3%) reported recent sei­
zures than persons with epilepsy at the highest annual house­
hold income level (20.9%). Similarly, a greater percentage of 
adults with active epilepsy who were unemployed or unable 
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to work (59.2%) reported recent seizures than adults with 
epilepsy who were employed (33.2%) or other groups (33.5%). 
Health-Related Quality of Life 
Compared with adults with no history of the disorder, adults 
with a history of epilepsy reported significantly more men­
tally unhealthy days (7.3 versus 3.2), physically unhealthy days 
(9.1 versus 3.5), overall unhealthy days (13.0 versus 5.9), and 
activity-limitation days (6.8 versus 2.1) (Table 8). Compared 
with those with no history of epilepsy, adults with active epi­
lepsy reported significantly more mentally unhealthy days (9.3 
versus 3.4), physically unhealthy days (10.7 versus 3.6), over­
all unhealthy days (15.1 versus 6.1), and activity-limitation 
days (8.4 versus 2.2) (Table 8). Similarly, adults with inactive 
epilepsy reported more mentally unhealthy days, physically 
unhealthy days, overall unhealthy days, and activity-
limitation days than those with no history of the disorder 
(Table 8). Adults with active epilepsy with recent seizures 
reported significantly more physically unhealthy days than 
those with no recent seizures (13.1 versus 8.8) and more 
activity-limitation days (11.1 versus 6.4) than those with no 
recent seizures. 
Discussion 
Population-based epidemiological studies of epilepsy are 
important for policymakers and health-care providers to plan 
and provide prevention programs and appropriate care and 
services for those affected (1,10). Adults with a history of epi­
lepsy and with active epilepsy were more likely to report nega­
tive health outcomes, and they face substantial socioeconomic 
disadvantages such as unemployment and low household 
income. In addition, these findings highlight the substantial 
adverse effects of recurring seizures on daily activities and 
HRQOL in adults with epilepsy. However, because of the cross-
sectional nature of BRFSS, no causality among the associa­
tions found can be inferred. 
Although prevalence estimates differed among certain states, 
these differences might have been a result of random error 
associated with response rates, response bias, or multiple com­
parisons. The estimates of persons who were ever told they 
had epilepsy (i.e., lifetime prevalence) and active epilepsy are 
comparable to previous estimates from the 1998 Texas BRFSS 
(lifetime prevalence, 1.8%), 2002 Georgia BRFSS (lifetime 
prevalence, 1.7%), and 2003 and 2004 South Carolina BRFSS 
surveys (lifetime prevalence, 2.2%; active epilepsy, 1.1%) and 
with estimates from the 2003 CHIS (lifetime prevalence, 1.2%; 
active epilepsy, 0.7%) (13–16). The active epilepsy estimate 
of 0.8% also is comparable to results from a recent study of a 
managed care population (0.7%); a 1978 door-to-door sur­
vey of all household and institutionalized residents in Copiah 
County, Mississippi (1%); and a community-based study of 
diagnostic records for 5 decennial census years in Minnesota 
(0.7%) (21–23) 
Despite methodologies that differed from those used in other 
studies, self-reports of medication use and seizure frequency 
from this study were comparable to findings from the 2003 
CHIS (16), the 2003 and 2004 South Carolina BRFSS sur­
veys (14), the 2004 HealthStyles Survey (17), and Copiah 
County, Mississippi (22). For example, in California, 10% of 
adults with active epilepsy reported not taking any medica­
tion for their seizure disorder, and 29% reported having had 
more than one seizure during the past 3 months (16). 
The finding in this report that epilepsy prevalence was lower 
among older adults differs from findings in other studies that 
have shown an increased prevalence with increased age (23); 
however, this study excluded institutionalized older adults from 
BRFSS, which might have resulted in the lower estimate. Like 
this study, other U.S. studies have not found consistent 
differences in the prevalence of epilepsy by sex or by race 
(15–17,22–26). 
Findings from this study regarding educational attainment, 
employment, marital status, and household income among 
persons with a history of epilepsy are comparable to those 
from other U.S. studies based on convenience samples of per­
sons with epilepsy and with longitudinal studies in Canada 
and Europe (27–29). Researchers who conducted cohort stud­
ies of children with epilepsy found a higher prevalence of psy­
chosocial problems, unemployment, and financial dependency 
and lower levels of education at adulthood compared with 
controls and suggested that ongoing psychosocial support is 
needed for children with epilepsy as they transition into adult­
hood (27). The higher percentages of adults with epilepsy at 
lower levels of education and income in this study are consis­
tent with findings from the 2002 Georgia BRFSS and 2002 
Tennessee BRFSS, which found that 22% of adults with a 
history of epilepsy did not complete high school and 44% 
had an annual household income of <$25,000; in addition, 
in the 2003 CHIS, 45% of Californians with epilepsy reported 
an annual household income <$25,000 (15,16). However, the 
results of this study indicate that although nearly half of adults 
with active epilepsy in 2005 had completed some college or 
more, many of these adults remained at lower household 
income levels. For example, 32% (CI = 22.7–42.7) of adults 
with active epilepsy who either had some college experience 
or completed college reported an annual household income 
of <$25,000, although only 15% (CI = 14.5–15.9) of adults 
with no history of the disorder and comparable education 
reported an income of <$25,000. Epilepsy and its treatment 
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can impair cognition, limiting academic achievement in some 
students with epilepsy (30,31), which might contribute to the 
lower educational attainment among adults with epilepsy. 
Lower levels of household income might be associated with 
periods of unemployment, disability status, or other factors 
unaccounted for in this study. Because these data are cross-
sectional, no causal associations between epilepsy and lower 
levels of education and income can be inferred. The finding 
of lower rates of marriage and partnership in this analysis 
among adults with a history epilepsy is similar to findings 
from the 2003 CHIS, in which only 45% of adults with epi­
lepsy were married, compared with 55% of adults without 
the disorder (16). This might result from decreased social 
opportunities among some persons with epilepsy (e.g., from 
limited access to transportation or to certain educational or 
occupational opportunities) or from stigma associated with 
the disorder (11,32). In addition, a higher percentage of adults 
with a history of epilepsy reported being formerly married 
compared with those without the disorder, which might be a 
result of the challenges of living with a chronic condition and 
the strain it might have on close relationships (33,34). Higher 
rates of divorce were found among persons with a history of 
epilepsy who did not disclose their epilepsy before marriage 
(35,36) and among those whose seizures had remitted (37). 
Persons with a history of epilepsy and active epilepsy are 
more likely than those without such histories to be obese, 
physically inactive, and current smokers (15,16). The stress 
of living with a chronic disorder such as epilepsy, including its 
social limitations, might encourage unhealthy coping behav­
iors (e.g., smoking and poor diet) and discourage healthy 
behaviors (e.g., physical activity). Persons with a history of 
epilepsy experience more depression and anxiety than those 
without the disorder; these common comorbid conditions are 
associated with unhealthy coping behaviors (38–40). In addi­
tion, certain anticonvulsant medications can cause sedation 
and lethargy, which might impede physical activity, whereas 
others can stimulate appetite, resulting in weight gain (41,42). 
Although persons with epilepsy historically have been discour­
aged from participating in physical activity because of con­
cerns about inducing seizures or sustaining injuries associated 
with seizures, physical activity can improve seizure control, 
mood, and quality of life (43,44). Although persons with epi­
lepsy should avoid physical injuries, many can benefit from 
daily physical activity such as walking (44–46). 
The higher reported prevalence of obesity, physical inactiv­
ity, and current smoking among persons with a history of epi­
lepsy might be a factor in the higher reported prevalence of 
self-reported heart disease, stroke, diabetes, and arthritis among 
these persons. In addition, certain underlying brain disorders 
can lead to decreased mobility and epilepsy. Other studies have 
found higher prevalence of comorbid illnesses in persons with 
epilepsy compared with the general population (47,48). 
Epilepsy and its treatment have been associated with 
co-occurring disorders and disease risk factors (e.g, cerebrovas­
cular and cardiovascular disorders, obstructive sleep apnea, 
and depression) (47–58). Because certain comorbid condi­
tions might occur before epilepsy onset, occur simultaneously 
with epilepsy onset, or result from the condition or its treat­
ment, additional studies are required to identify causal asso­
ciations and shared disease pathways (47–58). Physicians 
treating persons with epilepsy should screen for and treat these 
chronic disease comorbidities and their risk factors (58,59). 
When recommending treatment options, health-care provid­
ers also should consider the effects of antiepileptic drugs on 
risk factors (e.g., weight gain, mood disorders, and sleep prob­
lems) and health status (41,42,57,60,61). In addition, gen­
eral health-promotion information (e.g., smoking cessation, 
physical activity and healthy diet, and heart disease preven­
tion) might be useful for providers and Epilepsy Foundation 
affiliates to distribute to patients with epilepsy. 
The findings in this study regarding inadequate seizure con­
trol by medications might partly be a result of limited knowl­
edge of current diagnostic and treatment standards for the 
care of epilepsy among certain groups of health care profes­
sionals (62,63). Clinical tools and guidelines recommended 
for epilepsy care are available to improve clinical evaluation 
and services for patients with epilepsy (59,64,65). Inadequate 
seizure control might also arise, in part, from the difficulties 
with maintaining therapy regimens. Epilepsy medication regi­
mens typically require multiple daily doses (and sometimes 
multiple drugs) that must be taken consistently; patients can 
have difficulty strictly adhering to these requirements, result­
ing in seizure recurrence. Lapses in treatment adherence also 
might arise among patients with discontinuous or inadequate 
health insurance coverage when such patients are unable to 
afford medication. Finally, nearly 40% of epilepsy cases with 
partial seizures are considered refractory (i.e., resistant to medi­
cal therapy), resulting in occasional or frequent seizure recur­
rences despite optimal treatment with antiepileptic drugs (64). 
Persons with epilepsy might have difficulties finding and 
navigating through health-care and public services that could 
be helpful. Collaborative care models such as the chronic care 
model (66–69) also might improve health outcomes for per­
sons with epilepsy. For example, the Awareness and Access to 
Care for Children and Youth with Epilepsy (AACYE) initia­
tive focuses on timely clinical follow-up care with medical 
specialists, including screening and referral for behavioral and 
mental health needs, and an individualized patient- and family-
centered care plan (70). Community-based strategies (e.g., that 
include public transportation or telemedicine) that provide 
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hard-to-reach persons with epilepsy with access to social ser­
vices might also be helpful; these strategies have been effective 
for persons with complex chronic conditions (71–73). 
Adults with a history of epilepsy reported substantially worse 
self-rated health and HRQOL, more dissatisfaction with emo­
tional support received, and more overall dissatisfaction with 
life than adults without the disorder. Depression has been 
shown to be one of the strongest predictors of quality of life 
in persons with epilepsy (64). Although this analysis could 
not control for confounding effects of depression on HRQOL, 
a recent similar study found that adjusting for covariates such 
as race/ethnicity and income and chronic disease comorbidity 
made no difference in HRQOL estimates in persons with self-
reported epilepsy or active epilepsy (16). 
Adults with inactive epilepsy also reported worse HRQOL 
than those without the disorder, consistent with previous find­
ings (14,16). A diagnosis of epilepsy earlier in life, despite its 
resolution or remission, can still interfere with later life 
opportunities and alter perceptions of health status (27,74–76). 
In addition, some persons with epilepsy who achieve a reduc­
tion in number of seizures or complete seizure remission con­
tinue to experience psychosocial distress associated with unmet 
or unrealistic life expectations (76). 
The results of this study are subject to at least seven limita­
tions. First, the data are self-reported and subject to recall bias 
and response bias. However, the estimates collected for sev­
eral years are in general agreement, indicating these types of 
bias might be minimal (13–17). Second, because the survey is 
cross-sectional, no causal associations among variables can be 
inferred. Third, the reported cases of epilepsy are not classi­
fied by seizure type, severity, or etiology, and certain acute 
symptomatic seizures or nonepileptic seizures (NESs) might 
have been misclassified as epilepsy. However, given the small 
percentages of adults with NESs, significant skewing of 
results because of these cases is unlikely (77). In addition, many 
adults with NESs also have epileptic seizures, making such 
distinctions less likely to substantially skew results (78,79). 
Fourth, the higher number of days of impaired HRQOL in 
persons with inactive epilepsy compared with those without 
the disorder might also have resulted from the case definition, 
which was based on a 3-month recall period for seizure fre­
quency and is more conservative than the 5-year recall period 
recommended by the International League Against Epilepsy 
(ILAE) (4). Thus, some inactive cases in this study would have 
been classified as active cases using the ILAE definition. The 
case definition in this study was used to minimize difficulties 
in respondent recall of potentially numerous seizures over a 
lengthy interval, whereas the ILAE approach is designed for 
epidemiologic studies based on record review. Fifth, the analysis 
was unable to control for the possible effects of mood disor­
der on HRQOL in this study. Investigators might be able to 
do so in future BRFSS studies using data from states that 
included the Patient Health Questionnaire Survey or the 
Kessler-6 Psychological Distress scale along with the epilepsy 
questions (18). Sixth, epilepsy prevalence might be underesti­
mated because of underreporting resulting from the stigma 
associated with disclosing epilepsy and because BRFSS meth­
odology excludes institutionalized adults. Finally, BRFSS 
excludes households without landline telephones. However, 
the National Center for Health Statistics found that the per­
centage of households without landline phones is still low, 
and bias for persons who used cellular telephones exclusively 
was associated with select sociodemographic factors (80). 
CDC-supported Prevention Research Centers (PRCs) are 
conducting community-based research on self-management 
and depression prevention to improve health outcomes in 
persons with epilepsy (81–83). Pilot testing of WebEase (Web 
Epilepsy Awareness, Support, and Education), an Internet-
based program that is focused on behavioral change theory 
and tailored communication strategies, found significant 
improvements in overall self-management and other health 
outcomes among adults with epilepsy (84,85). 
Although this study identified effects of epilepsy on per­
sons in several states, additional descriptive and analytic stud­
ies of epilepsy occurrence in various U.S. communities and 
populations are needed. CDC is supporting the development 
of international standards for studies of epilepsy incidence and 
prevalence. Such research will better characterize epilepsy 
incidence rates, risk factors and etiologies, types, severity, 
associated conditions, and disability (1,10). 
The Association of State and Territorial Chronic Disease 
Directors endorsed a role for state public health departments 
in developing epilepsy surveillance capacity and establishing 
strong working relationships with other government agencies 
and with nongovernmental lay and professional groups (86). 
State and local public health agencies can work with their 
local Epilepsy Foundation affiliates, other groups such as the 
Epilepsy Therapy Project (available at http://www.epilepsy.com) 
that support persons with epilepsy and their families, and social 
service agencies to promote awareness and reduce social stigma, 
provide community and professional education about epilepsy, 
address employment and transportation needs, and provide 
referral and support for health promotion and disease preven­
tion for persons with epilepsy (86–91). 
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TABLE 1. Prevalence of adults with a history of epilepsy* and estimated prevalence of active and inactive epilepsy,† by state — 
19 states, Behavioral Risk Factor Surveillance System, 2005 
Total with history of epilepsy Active epilepsy Inactive epilepsy Total 
State sample size No. % (95 % CI§) No. % (95% CI) No. % (95% CI) 
Total 120,845 2,207 1.65 (1.52–1.80) 919 0.84 (0.74–0.96) 693 0.75 (0.65–0.86) 
Arizona 4,407 61 1.35 (0.84–2.16) 36 0.46¶ (0.27–0.80) 24 0.89¶ (0.46–1.71) 
Delaware 4,129 54 1.15 (0.81–1.62) 20 0.43¶ (0.25–0.75) 33 0.69¶ (0.44–1.09) 
Florida 7,753 136 1.61 (1.25–2.06) — — — — — — 
Georgia 5,783 104 1.71 (1.29–2.27) 59 0.77 (0.55–1.08) 45 0.94 (0.61–1.46) 
Kansas 4,211 70 1.75 (1.31–2.34) — — — — — — 
Kentucky 6,164 165 2.17 (1.75–2.69) 88 1.14 (0.87–1.50) 74 0.98 (0.69–1.39) 
Michigan 11,798 219 1.79 (1.53–2.09) 127 0.96 (0.78–1.18) 90 0.81 (0.63–1.04) 
Missouri 4,873 88 1.77 (1.28–2.45) 45 0.71 (0.47–1.07) 41 1.00¶ (0.61–1.63) 
New Hampshire 5,731 98 1.61 (1.27–2.05) — — — — — — 
New York 3,571 53 1.29 (0.9–1.76) 33 0.87 (0.59–1.28) 20 0.42¶ (0.25–0.70) 
Oregon 9,602 183 1.84 (1.55–2.18) 115 1.03 (0.83–1.27) 65 0.78 (0.58–1.05) 
Pennsylvania 12,474 207 1.58 (1.28–1.94) 130 0.93 (0.71–1.22) 74 0.64 (0.45–0.89) 
South Carolina 7,992 151 1.69 (1.40–2.04) 85 0.88 (0.69–1.12) 66 0.81 (0.61–1.09) 
Tennessee 4,427 93 2.07 (1.57–2.73) 54 1.02 (0.74–1.40) 35 0.93¶ (0.58–1.48) 
Texas 5,901 102 1.73 (1.29–2.33)  — — — — — — 
Virginia 5,064 88 1.96 (1.51–2.56)  — — — — — — 
Washington 7,848 148 1.65 (1.34–2.03) 67 0.69 (0.51–0.94) 79 0.94 (0.71–1.24) 
Wisconsin 4,294 80 1.64 (1.26–2.13)  — — — — — — 
Wyoming 4,823 107 2.20 (1.77–2.73) 60 1.24 (0.93–1.65) 47 0.96 (0.68–1.34) 
* Self-reported epilepsy as determined by affirmative response to the question “Have you ever been told by a doctor that you have a seizure disorder or 
epilepsy?”
†Respondents were classified as having active epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder or 
epilepsy and also responded that they either were currently taking medication for epilepsy, had one or more seizures in the preceding 3 months, or 
both. Respondents were classified as having inactive epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure 
disorder or epilepsy but were not taking medication for epilepsy and had not had a seizure in the preceding 3 months. Dashes indicate that the states 
did not include the questions on epilepsy medication and seizure frequency.
§Confidence interval.
 
¶ Relative standard error of the estimate is >30%; estimate is unreliable.
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TABLE 2. Number and percentage of adults with and without a history of epilepsy,* by selected characteristics — 19 states,† 
Behavioral Risk Factor Surveillance System, 2005 
With history of epilepsy  Without history of epilepsy 
Total (n = 2,207) (n = 118,638) 
Characteristic sample size No. % (95% CI§) No. % (95% CI) 
Sex 
Male 45,701 805 44.1 (40.0–48.2) 44,896 48.3 (47.7–48.9) 
Female 75,144 1,402 55.9 (51.8–60.0) 73,742 51.7 (51.1–52.3) 
Age (yrs) 
18–24 6,134 90 12.3 (8.8–17.0) 6,044 12.8 (12.3–13.4) 
25–34 15,225 277 18.9 (15.6–22.8) 14,948 17.7 (17.3–18.2) 
35–44 21,071 446 22.0 (19.0–25.4) 20,625 19.8 (19.3–20.2) 
45–54 24,894 594 22.7 (19.8–26.0) 24,300 18.5 (18.1–18.9) 
55–64 22,397 417 12.1 (10.1–14.4) 21,980 13.9 (13.5–14.2) 
65–74 17,023 239 7.7 (6.2–9.5) 16,784 9.1 (8.9–9.4) 
>75 13,371 134 4.3 (3.2–5.7) 13,237 8.1 (7.9–8.4) 
Race/Ethnicity 
White 99,349 1,786 74.1 (69.4–78.3) 97,563 74.2 (73.7–74.8) 
Black 9,451 176 8.8 (6.6–11.5) 9,275 9.4 (9.0–9.7) 
Hispanic 6,534 106 11.2 (8.2–15.0) 6,428 11.6 (11.1–12.0) 
Other 4,393 107 6.0 (3.5–10.0) 4,286 4.8 (4.6–5.1) 
Education 
Less than high school 12,588 323 16.1 (13.2–19.5) 12,265 11.3 (10.9–11.7) 
High school graduate 38,475 771 35.7 (31.7–40.0) 37,704 30.1 (29.6–30.6) 
Some college or college graduate 69,544 1,112 48.2 (44.1–52.3) 68,432 58.6 (58.1–59.2) 
Income 
<$25,000 31,431 905 40.9 (36.7–45.2) 30,526 26.3 (25.8–26.9) 
$25,000–$49,999 32,847 511 30.0 (25.6–34.5) 32,336 29.7 (29.2–30.2) 
>$50,000 39,943 457 29.2 (25.4–33.4) 39,486 43.9 (43.3–44.5) 
Marital status 
Married or unmarried couple 70,335 1,083 55.5 (51.3–59.7) 69,252 64.1 (63.6–64.7) 
Formerly married 35,015 752 22.9 (20.0–26.2) 34,263 18.0 (17.6–18.3) 
Never married 15,115 361 21.5 (17.7–26.0) 14,754 17.9 (17.4–18.4) 
Employment status 
Employed 66,323 891 45.8 (41.6–50.0) 65,432 61.6 (61.1–62.1) 
Unemployed 4,953 127 6.8 (5.0–9.0) 4,826 5.0 (4.8–5.3) 
Unable to work 7,443 593 23.7 (20.5–27.2) 6,850 4.8 (4.6–5.0) 
Other (homemaker, student, or retired) 41,808 590 23.7 (20.5–27.3) 41,218  28.6 (28.1–29.0) 
Health-care insurance 
Yes 105,833 1,891 83.0 (79.5–86.1) 103,942 83.7 (83.2–84.1) 
No 14,697 313 17.0 (13.9–20.5) 14,384 16.3 (15.9–16.8) 
Could not visit doctor because of cost 
Yes 15,076 491 23.7 (20.2–27.5) 14,585 13.4 (13.0–13.8) 
No 105,510 1,708 76.3 (72.5–79.8) 103,802 86.6 (86.2–87.0) 
* Self-reported epilepsy as determined by response to the question “Have you ever been told by a doctor that you have a seizure disorder or epilepsy?” 
† Arizona, Delaware, Florida, Georgia, Kansas, Kentucky, Michigan, Missouri, New Hampshire, New York, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, 
Virginia, Washington, Wisconsin, and Wyoming.
§ Confidence interval. 
¶ Relative standard error of the estimate is >30%; estimate is unreliable. 
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TABLE 2. (Continued ) Number and percentage of adults with and without a history of epilepsy,* by selected characteristics — 19 
states,† Behavioral Risk Factor Surveillance System, 2005 
With history of epilepsy  Without history of epilepsy 
Total (n = 2,207) (n = 118,638) 
Characteristic sample size No. % (95% CI§) No. % (95% CI) 
Length of time since last checkup 
Within past year 84,938 1,569 69.0 (65.0–72.7) 83,369 67.9 (67.4–68.5) 
Within past 2 years 15,095 253 11.9 (9.4–14.9) 14,842 14.1 (13.7–14.5) 

















Body mass index 
Underweight (<18.5 kg/m2) 
Normal weight (18.5–24.9 kg/m2) 
Overweight (25.0–29.9 kg/m2) 






























Current smoker 24,372 682 30.1 (26.5–33.9) 23,690 20.9 (20.4–21.4) 
Former smoker 34,566 596 23.3 (20.3–26.6) 33,970 25.2 (24.7–25.6) 
Never smoked 61,389 925 46.6 (42.4–50.8) 60,464 53.9 (53.4–54.5) 
Exercise in last 30 days 
Yes 89,383 1,382 66.5 (62.8–70.0) 88,001 75.5 (75.0–76.0) 
No 31,341 818 33.5 (30.0–37.2) 30,523 24.5 (24.0–25.0) 
Alcohol consumption in past month 
Yes 60,455 809 41.2 (37.1–45.5) 59,646 54.2 (53.6–54.7) 
No 60,180 1,396 58.8 (54.5–62.9) 58,784 45.8 (45.3–46.4) 
Self-rated health. 
Good, very good, or excellent 97,852 1,257 63.0 (59.0–66.8) 96,595 84.2 (83.8–84.6) 
Fair or poor 22,609 932 37.0 (33.2–41.0) 21,677 15.8 (15.4–16.2) 
Receipt of emotional support 
Always or usually 93,308 1,440 65.6 (61.5–69.5) 91,868 78.9 (78.4–79.4) 
Sometimes 15,897 405 20.7 (17.5–24.4) 15,492 13.1 (12.7–13.5) 
Rarely or never 9,492 321  13.6 (11.0–16.8) 9,171 8.0 (7.7–8.3) 
Life satisfaction 
Very satisfied or satisfied 112,554 1,793 83.4 (80.0–86.2) 110,761 94.6 (94.3–94.8) 
Dissatisfied or very dissatisfied 7,408 381 16.6 (13.8–20.0) 7,027 5.4 (5.2–5.7) 
* Self-reported epilepsy as determined by response to the question “Have you ever been told by a doctor that you have a seizure disorder or epilepsy?”
† Arizona, Delaware, Florida, Georgia, Kansas, Kentucky, Michigan, Missouri, New Hampshire, New York, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, 
Virginia, Washington, Wisconsin, and Wyoming.
§ Confidence interval. 
¶ Relative standard error of the estimate is >30%; estimate is unreliable. 
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TABLE 3. Percentage of adults taking medication to control seizure disorder or epilepsy, having seizures in past 3 months, 
visiting a neurologist in the past year, and having activity limitations among adults with a history of epilepsy* and active epilepsy — 
13 states,† Behavioral Risk Factor Surveillance System, 2005 
Active epilepsy¶ 
Total with Total with Any seizures No seizures 
history of epilepsy Inactive epilepsy¶ active epilepsy in past 3 months in past 3 months 
(n = 1,626) (n = 693) (n = 919) (n = 377) (n = 515) 
Characteristic % (95% CI§) % (95% CI) % (95% CI) % (95% CI) % (95% CI) 
Currently taking medication
 to control seizure disorder 
or epilepsy 
Yes 48.8 (44.1–53.6) — — 93.1 (90.3–95.1) 83.9 (77.6–88.7) 100.0 —
 
No 51.2 (46.4–55.9) — — 6.9 (4.9–9.7) 16.1 (11.3–22.4) 0 —
 
Number of seizures in last 
3 months 
None 71.0 (66.5–75.2) 88.7 (83.3–92.5) 55.1 (48.6–61.5) 0 — 98.2 (95.1–99.4) 
One 8.1 (5.8–11.1) 0 — 15.3 (11.1–20.7) 34.9 (26.0–45.0) 0 — 
More than one 15.0 (11.9–18.9) 0 — 28.6 (23.0–34.9) 65.1 (55.0–74.0) 0 — 
No longer have 5.9 (4.0–8.6) 11.3 (7.5–16.7) 1.0 (0.3–2.8)** — — 1.8 (0.6–4.9)** 
Visited neurologist in past year 
Yes 40.5 (35.4–45.8) 14.9 (9.3–23.0) 62.0 (55.3–68.2) 65.1 (53.8–74.8) 59.4 (50.7–67.5) 
No 59.5 (54.2–64.6) 85.1 (77.0–90.7) 38.0 (31.8–44.7) 34.9 (25.2–46.2) 40.6 (32.5–49.3) 
Extent that epilepsy or its 
treatment limited activities 
in past month 
No limitations 74.7 (69.8–79.1) 95.0 (90.5–97.4) 57.9 (50.9-64.7) 34.9 (25.3–45.9) 76.5 (66.7–84.0) 
Slightly or moderately 13.8 (10.9–17.5) 2.5 (1.0–5.7) 23.2 (18.1-29.2) 32.2 (23.9–41.8) 16.0 (9.8–24.9) 
Quite a bit or extremely 11.4 (8.1–15.9) 2.5 (0.9–6.8) 18.9 (13.3-26.0) 32.9 (22.7–45.0) 7.6 (3.5–15.8) 
* Self-reported epilepsy as determined by an affirmative response to the question “Have you ever been told by a doctor that you have a seizure disorder 
or epilepsy?”




¶ Respondents were classified as having active epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder or
 
epilepsy and also responded that they either were currently taking medication for epilepsy, had one or more seizures in the preceding 3 months, or both. 
Respondents were classified as having inactive epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder 
or epilepsy but were not taking medication for epilepsy and had not had a seizure in the preceding 3 months. 
** Respondents who reported taking medication for epilepsy (i.e., were classified as having active epilepsy). 
 
15 Vol. 57 / SS-6 Surveillance Summaries 
TABLE 4. Estimated prevalence of active and inactive epilepsy* among adults, by sex, age, and race/ethnicity — 13 states,† 
Behavioral Risk Factor Surveillance System, 2005 
Total Active epilepsy Inactive epilepsy 
Characteristic sample size No. % (95% CI§) No. % (95% CI) 
Total 87,891 919 0.84 (0.74–0.96) 693 0.75 (0.65–0.86) 
Sex 
Male 32,954 333 0.77 (0.62–0.95) 231 0.69 (0.55–0.88) 
Female 54,937 586 0.92 (0.79–1.07) 462 0.80 (0.67–0.95) 
Age (yrs) 
18–24 4,457 18 0.35¶ (0.19–0.67) 40 0.79¶ (0.48–1.3) 
25–34 11,041 103 0.92 (0.61–1.37) 94 0.81 (0.55–1.2) 
35–44 15,143 165 0.95 (0.73–1.24) 158 0.97 (0.73–1.3) 
45–54 18,147 260 1.18 (0.95–1.46) 180 0.82 (0.63–1.1) 
55–64 16,436 177 0.79 (0.60–1.02) 132 0.63 (0.47–0.85) 
65–74 12,501 121 0.87 (0.62–1.22) 58 0.54 (0.41–0.98) 
>75 9,691 68 0.53 (0.32–0.86) 30 0.23 (0.12–0.43) 
Race/Ethnicity 
White 73,151 756 0.87 (0.75–0.99) 561 0.72 (0.62–0.84) 
Black 7,220 74 0.89 (0.55–1.45) 63 0.71 (0.45–1.10) 
Hispanic 3,502 30 0.66¶ (0.33–1.32) 25 0.90¶ (0.40–1.98) 
Other 3,239 42 0.51¶ (0.26–0.98) 34 0.81¶ (0.42–1.53) 
* Respondents were classified as having active epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder or
 
epilepsy and also responded that they either were currently taking medication for epilepsy, had one or more seizures in the preceding 3 months, or
 
both. Respondents were classified as having inactive epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure
 
disorder or epilepsy but were not taking medication for epilepsy and had not had a seizure in the preceding 3 months.





¶ Relative standard error of the estimate is >30%; estimate is unreliable.
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TABLE 5. Number and percentage of adults with and without a history of epilepsy,* by selected characteristics and epilepsy 
status† — 13 states,§ Behavioral Risk Factor Surveillance System, 2005 
With history of epilepsy 
Without history of epilepsy Active epilepsy Inactive epilepsy 
(n = 86,258) (n = 919) (n = 693) 
Characteristic No. % (95% CI¶) No. % (95% CI) No. % (95% CI) 
Sex 
Male 32,380 48.1 (47.4–48.8) 333 43.6 (37.1–50.2) 231 44.6 (37.5–52.0) 
Female 53,878 51.9 (51.2–52.6) 586 56.4 (49.8–62.9) 462 55.4 (48.0–62.5) 
Age (yrs) 
18–24 4,397 12.8 (12.1–13.5) 18 5.3** (2.9–9.7) 40 13.4 (8.4–20.7) 
25–34 10,842 17.9 (17.3–18.4) 103 19.4 (13.6–26.8) 94 19.6 (13.7–27.1) 
35–44 14,819 19.6 (19.1–20.1) 165 22.1 (17.2–27.8) 158 25.7 (20.0–32.5) 
45–54 17,700 18.6 (18.1–19.1) 260 26.1 (21.3–31.5) 180 20.5 (15.9–25.9) 
55–64 16,123 14.0 (13.6–14.4) 177 13.0 (10.0–16.8) 132 11.9 (8.8–16.0) 
65–74 12,320 8.8 (8.6–9.1) 121 9.1 (6.5–12.6) 58 6.3 (4.1–9.8) 
>75 9,590 8.3 (8.0–8.6) 68 5.1 (3.1–8.3) 30 2.5* (1.3–4.8) 
Race/Ethnicity 
White 71,816 77.6 (76.9–78.2) 756 80.4 (73.8–85.7) 561 76.1 (68.0–82.6) 
Black 7,081 10.2 (9.8–10.7) 74 11.0 (6.9–16.9) 63 9.8 (6.3–14.8) 
Hispanic 3,447 7.0 (6.5–7.5) 30 5.5** (2.8–10.6) 25 8.5* (3.9–17.3) 
Other 3,163 5.2 (4.9–5.6) 42 3.2 (1.6–6.0) 34 5.7* (3.0–10.4) 
Education 
Less than high school 8,923 10.4 (10.0–10.9) 139 15.9 (11.9–20.9) 107 16.7 (12.0–22.8) 
High school graduate 28,010 31.6 (31.0–32.3) 341 37.0 (31.1–43.2) 225 34.0 (27.6–41.1) 
Some college or college graduate 49,165 58.0 (57.3–58.7) 439 47.1 (40.7–53.6) 361 49.3 (42.1–56.4) 
Income 
<$25,000 22,654 26.5 (25.8–27.2) 433 47.7 (40.7–54.9) 253 40.7 (33.4–48.4) 
$25,000–$49,999 23,544 29.8 (29.2–30.5) 183 26.3 (20.7–32.9) 187 26.4 (20.6–33.2) 
>$50,000 28,043 43.7 (43.0–44.4) 151 26.0 (19.7–33.4) 156 32.9 (25.6–41.1) 
Marital status 
Married or unmarried couple 50,029 62.5 (61.8–63.2) 424 53.9 (47.4–60.2) 347 58.0 (50.9–64.8) 
Formerly married 25,055 18.2 (17.8–18.7) 335 26.6 (21.7–32.3) 230 22.2 (17.7–27.5) 
Never married 10,913 19.2 (18.6–20.0) 154 19.5 (14.6–25.7) 113 19.8 (14.3–26.8) 
Employment status 
Employed 46,804 61.2 (60.5–61.9) 265 36.0 (30.0–42.6) 356 55.4 (48.2–62.3) 
Unemployed 3,569 5.4 (5.1–5.9) 62 9.8 (6.4–14.6) 35 8.3** (4.8–14.1) 
Unable to work 5,213 4.9 (4.6–5.1) 316 31.3 (25.6–37.6) 131 15.4 (11.5–20.3) 
Other (homemaker, student, or retired) 30,442 28.5 (27.9–29.1) 272 22.9 (18.4–28.1) 169 20.9 (16.0–27.0) 
* Self-reported epilepsy as determined by response to the question “Have you ever been told by a doctor that you have a seizure disorder or epilepsy?” 
† Respondents were classified as having active epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder or 
epilepsy and also responded that they either were currently taking medication for epilepsy, had one or more seizures in the preceding 3 months, or both. 
Respondents were classified as having inactive epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder 
or epilepsy but were not taking medication for epilepsy and had not had a seizure in the preceding 3 months.
§ Arizona, Delaware, Georgia, Kentucky, Michigan, Missouri, New York, Oregon, Pennsylvania, South Carolina, Tennessee, Washington, and Wyoming. 
¶ Confidence interval. 
** Relative standard error of the estimate is >30%; estimate is unreliable. 
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TABLE 6. Number and percentage of adults with and without a history of epilepsy,* by risk factors, comorbid conditions, and 
epilepsy status† — 13 states,§ Behavioral Risk Factor Surveillance System, 2005 
With history of epilepsy 
Without history of epilepsy Active epilepsy Inactive epilepsy 
(n = 86,258) (n = 919) (n = 693) 
Characteristic No. % (95% CI¶) No. % (95% CI) No. % (95% CI) 
Self-rated health 
Good or excellent 69,824 84.2 (83.7–84.7) 444 51.5 (45.0–57.9) 460 71.5 (65.4–76.8) 
Fair or poor 16,198 15.8 (15.3–16.3) 468 48.5 (42.1–55.0) 228 28.5 (23.2–34.6) 
Health-care insurance 
Yes 75,936 85.9 (85.3–86.4) 808 89.1 (85.1–92.2) 572 76.1 (68.8–82.1) 
No 10,121 14.1 (13.6–14.7) 111 10.9 (7.8–14.9) 121 23.9 (17.9–31.2) 
Could not visit doctor because of cost 
Yes 10,613 12.8 (12.3–13.3) 201 20.4 (15.7–26.0) 162 24.7 (18.8–31.6) 
No 75,469 87.2 (86.7–87.7) 716 79.6 (74.0–84.3) 528 75.3 (68.4–81.2) 
Checkup 
Within past year 60,048 67.5 (66.8–68.2) 679 71.5 (65.1–77.1) 465 63.1 (55.5–70.1) 
Within past 2 years 10,946 14.6 (14.0–15.1) 93 13.3 (8.9–19.3) 88 11.5 (7.7–16.9) 
Within past 5 years 6,412 8.7 (8.3–9.1) 65 7.8 (5.3–11.3) 60 11.2 (7.0–17.5) 
>5 years 6,616 8.0 (7.6–8.3) 56 6.9 (4.3–10.7) 64 13.7 (8.8–20.7) 
Never 966 1.2 (1.1–1.4) — — — — — — 
Body mass index 
Underweight (<18.5 kg/m2) 10,114 6.4 (6.2–6.6) 131 8.7 (6.7–11.2) 80 9.4 (6.0–14.3) 
Normal weight (18.5–24.9 kg/m2) 25,611 35.7 (35.0–36.4) 263 32.6 (26.7–39.0) 186 32.2 (25.7–39.6) 
Overweight (25.0–29.9 kg/m2) 26,773 34.6 (33.9–35.3) 233 26.6 (29.7–33.4) 210 26.5 (21.0–33.0) 
Obese (>30 kg/m2) 19,616 23.3 (22.7–23.9) 246 32.2 (26.3–38.7) 201 31.9 (25.3–39.2) 
Exercise in past 30 days 
Yes 63,905 75.4 (74.8–76.0) 539 60.7 (54.5–66.6) 468 71.7 (65.3–77.3) 
No 22,275 24.6 (24.0–25.2) 376 39.3 (33.4–45.5) 224 28.3 (22.7–34.7) 
Smoking status 
Current smoker 17,519 21.6 (21.0–22.2) 299 32.4 (26.4–39.0) 211 32.0 (25.7–39.1) 
Former smoker 24,661 25.5 (24.9–26.1) 251 26.5 (21.4–32.3) 188 21.7 (16.9–27.6) 
Never smoked 43,720 52.9 (52.2–53.6) 367 41.2 (35.0–47.6) 292 46.2 (39.1–53.5) 
Alcohol consumption in past month 
Yes 42,466 53.4 (52.7–54.1) 278 30.4 (25.0–36.4) 289 45.2 (38.1–52.5) 
No 43,641 46.6 (45.9–47.3) 640 69.6 (63.6–75.0) 404 54.8 (47.5–61.9) 
* Self-reported epilepsy as determined by response to the question “Have you ever been told by a doctor that you have a seizure disorder or epilepsy?” 
† Respondents were classified as having active epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder or epilepsy and also 
responded that they either were currently taking medication for epilepsy, had one or more seizures in the preceding 3 months, or both. Respondents were classified as 
having inactive epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder or epilepsy but were not taking medication for epilepsy 
and had not had a seizure in the preceding 3 months.
§ Arizona, Delaware, Georgia, Kentucky, Michigan, Missouri, New York, Oregon, Pennsylvania, South Carolina, Tennessee, Washington, and Wyoming. 
¶ Confidence interval. 
** Relative standard error of the estimate is >30%; estimate is unreliable. 
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TABLE 6. (Continued ) Number and percentage of adults with and without a history of epilepsy,* by risk factors, comorbid 
conditions, and epilepsy status† — 13 states,§ Behavioral Risk Factor Surveillance System, 2005 
With history of epilepsy 
Without history of epilepsy Active epilepsy Inactive epilepsy 
(n = 86,258) (n = 919) (n = 693) 
Characteristic No. % (95% CI¶) No. % (95% CI) No. % (95% CI) 
Ever told had a stroke 
Yes 2,857 2.4 (2.3–2.6) 168 15.7 (11.3–21.4) 58 7.3 (4.3–12.0) 
No 83,184 97.6 (97.4–97.7) 737 84.3 (78.6–88.7) 628 92.7 (88.0–95.7) 
Ever told had heart disease 
Yes 4,901 4.6 (4.3–4.8) 110 8.4 (5.6–11.8) 50 4.8 (3.0–7.4) 
No 80,635 95.4 (95.2–95.7) 793 91.6 (88.2–94.1) 635 95.2 (92.6–97.0) 
Ever told had asthma 
Yes 7,470 8.2 (7.8–8.6) 181 20.3 (15.3–26.4) 108 11.9 (8.1–17.0) 
No 78,324 91.8 (91.4–92.2) 727 79.7 (73.6–84.7) 576 88.1 (83.0–91.9) 
Ever told had diabetes 
Yes 8,841 7.7 (7.4–8.0) 120 13.0 (8.3–19.7) 91 14.9 (10.4–20.8) 
No 77,690 92.3 (92.0–92.6) 797 87.0 (80.3–91.7) 602 85.1 (79.2–89.6) 
Ever told had arthritis 
Yes 31,132 28.0 (27.5–28.6) 476 43.0 (37.0–49.2) 303 41.8 (34.8–49.1) 
No 54,736 72.0 (71.4–72.5) 440 57.0 (50.8–63.0) 389 58.2 (50.9–65.2) 
Current joint pain 
Yes 40,394 40.8 (40.2–41.5) 573 57.7 (51.1–64.1) 394 54.1 (46.8–61.2) 
No 45,673 59.2 (58.5–59.8) 343 42.3 (35.9–48.9) 299 45.9 (38.8–53.2) 
5 servings/day of fruits and vegetables 
Yes 25,391 26.4 (25.8–27.0) 275 21.6 (17.4–26.3) 193 27.4 (21.2–34.6) 
No 60,764 73.6 (73.0–74.2) 640 78.4 (73.7–82.6) 500 72.6 (65.4–78.8) 
Flu shot in past year 
Yes 26,809 26.0 (25.4–26.6) 323 32.5 (26.7–38.9) 190 23.1 (17.9–29.3) 
No 59,221 74.0 (73.4–74.6) 593 67.5 (61.1–73.3) 503 76.9 (70.7–82.1) 
Human immunodeficiency virus risk situations 
Yes 1,862 3.8 (3.4–4.2) 24 4.6** (2.4–8.7) 29 5.2** (2.6–9.9) 
No 62,267 96.2 (95.8–96.6) 703 95.4 (91.3–97.6) 576 94.8 (90.1–97.4) 
Receipt of emotional support 
Always or usually 66,901 79.0 (78.4–79.6) 571 59.3 (52.5–65.8) 468 66.6 (59.3–73.2) 
Sometimes 11,340 13.4 (12.9–13.9) 181 21.6 (16.3–27.9) 118 21.1 (15.8–27.6) 
Rarely or never 6,564 7.6 (7.2–8.0) 149 19.1 (14.0–25.6) 94 12.3 (7.9–18.6) 
Life satisfaction 
Very satisfied or satisfied 80,377 94.3 (93.9–94.6) 719 81.2 (76.3–85.3) 581 84.7 (78.1–89.6) 
Dissatisfied or very dissatisfied 5265 5.7 (5.4–6.1) 184 18.8 (14.7–23.7) 102 15.3 (10.4–21.9) 
* Self-reported epilepsy as determined by response to the question “Have you ever been told by a doctor that you have a seizure disorder or epilepsy?” 
† Respondents were classified as having active epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder or epilepsy and also 
responded that they either were currently taking medication for epilepsy, had one or more seizures in the preceding 3 months, or both. Respondents were classified as 
having inactive epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder or epilepsy but were not taking medication for epilepsy 
and had not had a seizure in the preceding 3 months.
§ Arizona, Delaware, Georgia, Kentucky, Michigan, Missouri, New York, Oregon, Pennsylvania, South Carolina, Tennessee, Washington, and Wyoming. 
¶ Confidence interval. 
** Relative standard error of the estimate is >30%; estimate is unreliable. 
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TABLE 7. Number and percentage of adults with active epilepsy* and any seizures within past 3 months, by selected characteristics 
— 13 states,† Behavioral Risk Factor Surveillance System, 2005 
Total with  Any seizures in past 3 months 
Characteristic active epilepsy No. % (95% CI§) 
Total 892¶ 377 43.9 (37.5–50.4) 
Sex 
Male 324 126 37.6 (27.7–48.7) 
Female 568 251 48.8 (40.9–56.6) 
Race/Ethnicity 
White 737 294 40.0 (33.6–46.8) 
Black 70 32 53.9 (30.4–75.7) 
Hispanic 28 17 79.2 (50.3–93.5) 
Other 41 24** 23.2 (9.9–45.4) 
Age (yrs) 
18–34 116 65 55.2 (37.7–71.5) 
35–44 162 85 46.3 (33.4–59.7) 
45–64 427 184 43.7 (35.5–52.3) 
>65 182 39** 20.1 (10.0–36.4) 
Income 
<$25,000 420 226 57.3 (47.5–66.5) 
$24,999–$49,999 183 65 44.0 (31.2–57.6) 
>$50,000 148 28** 20.9 (12.1–33.7) 
Employment status 
Employed 260 81 33.2 (23.8–44.1) 
Unemployed or unable to work 369 219 59.2 (49.0–68.7) 
Other (homemaker, student, or retired) 260 74 33.5 (23.2–45.7) 
* Respondents were classified as having active epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder or 
epilepsy and also responded that they either were currently taking medication for epilepsy, had one or more seizures in the preceding 3 months, or both. 




¶ Total number of persons with active epilepsy who provided a valid response to the question on seizure frequency.
 
** Relative standard error of the estimate is >30%; estimate is unreliable.
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TABLE 8. Health-related quality of life indicators among adults with and without a history of epilepsy,* by epilepsy status and 
seizure activity† — multiple states, Behavioral Risk Factor Surveillance System, 2005 
Indicators 
Mentally Physically Overall Activity-limitation 
unhealthy days unhealthy days unhealthy days days 
Epilepsy status No.§ No. (95% CI¶) No. (95% CI) No. (95% CI) No. (95% CI) 
With history of epilepsy** 2,150 7.3 (6.5–8.1) 9.1 (8.2–10.1) 13.0 (11.9–14.0) 6.8 (6.0–7.7) 
Without history of epilepsy** 117,279 3.2 (3.2–3.3) 3.5 (3.4–3.6) 5.9 (5.8–6.0) 2.1 (2.0–2.2) 
Epilepsy classification and seizure activity†† 
No history of epilepsy 85,223 3.4 (3.3–3.5) 3.6 (3.5–3.7) 6.1 (6.0–6.3) 2.2 (2.1–2.3) 
Inactive epilepsy 680 6.1 (5.0–7.3) 6.9 (5.4–8.5) 11.0 (9.2–12.8) 5.2 (4.1–6.3) 
Active epilepsy 895 9.3 (7.9–10.8) 10.7 (9.3–12.1) 15.1 (13.4–16.7) 8.4 (6.9–10.0) 
No seizures in past 3 months 507 7.6 (5.8–9.4) 8.8 (7.2–10.4) 13.0 (11.0–14.9) 6.4 (4.6–8.1) 
Any seizures in past 3 months 364 11.4 (9.1–13.7) 13.1 (10.7–15.5) 17.6 (14.9–20.2) 11.1 (8.4–13.8) 
* Self-reported epilepsy as determined by response to the question “Have you ever been told by a doctor that you have a seizure disorder or epilepsy?” 
† Respondents were classified as having active epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder or 
epilepsy and also responded that they either were currently taking medication for epilepsy, had one or more seizures in the preceding 3 months, or both. 
Respondents were classified as having inactive epilepsy if they responded “yes” to ever having been told by a doctor that they had a seizure disorder 
or epilepsy but were not taking medication for epilepsy and had not had a seizure in the preceding 3 months.
§ Sample size is based on largest number of respondents to health-related quality of life questions within epilepsy category.
¶ Confidence interval. 
** 19 states: Arizona, Delaware, Florida, Georgia, Kansas, Kentucky, Michigan, Missouri, New Hampshire, New York, Oregon, Pennsylvania, South 
Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin, and Wyoming.
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